Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F7UH1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,789
Award facts
- Contract value 100% obligated
- $21,788.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $21,788.73 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/mL packaging. This competitively awarded, firm fixed-price delivery order is non-set-aside and is scheduled for completion by December 8, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a standard pharmaceutical supply transaction supporting federal medical procurement needs.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value and extends through December 2026. As a prime contract vehicle, the IDC enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen is a major pharmaceutical distributor headquartered in Pennsylvania and represents a critical vendor for federal medical supply chains, with a demonstrated capability to fulfill competitive federal procurement requirements across diverse therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F7UH1?
SPE2DR26F7UH1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26F7UH1 worth?
The government has obligated $21,789 on SPE2DR26F7UH1.
Is contract SPE2DR26F7UH1 an order under another contract?
Yes. SPE2DR26F7UH1 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7UH1 competed?
The extent of competition for SPE2DR26F7UH1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award